{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:00:48Z","timestamp":1792119648429,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007817","name":"Alcon Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA125970"],"award-info":[{"award-number":["R01 CA125970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ajo.2018.07.045","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T05:20:54Z","timestamp":1533532854000},"page":"154-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma"],"prefix":"10.1016","volume":"195","author":[{"given":"Louis","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-9680","authenticated-orcid":false,"given":"Manuel","family":"Paez-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bercin","family":"Tarlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Decatur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.William","family":"Harbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2018.07.045_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1586\/17469899.2.6.939","article-title":"Current management of uveal melanoma","volume":"2","author":"Ramaiya","year":"2007","journal-title":"Expert Rev Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2018.07.045_bib2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0161-6420(03)00077-0","article-title":"Survival rates with uveal melanoma in the United States: 1973-1997","volume":"110","author":"Singh","year":"2003","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2018.07.045_bib3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea - Tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2018.07.045_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ophtha.2017.08.017","article-title":"Adjuvant sunitinib in high-risk patients with uveal melanoma: comparison with institutional controls","volume":"125","author":"Valsecchi","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2018.07.045_bib5","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.ophtha.2016.06.027","article-title":"Adjuvant dendritic cell vaccination in high-risk uveal melanoma","volume":"123","author":"Bol","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2018.07.045_bib6","series-title":"AJCC Cancer Staging Manual","year":"2016"},{"issue":"19","key":"10.1016\/j.ajo.2018.07.045_bib7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/jnci\/djh293","article-title":"Outcome prediction and the future of the TNM staging system","volume":"96","author":"Burke","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.ajo.2018.07.045_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(07)70205-X","article-title":"The future of the TNM staging system in colorectal cancer: time for a debate?","volume":"8","author":"Quirke","year":"2007","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ajo.2018.07.045_bib9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/ans.13277","article-title":"Long-term survivors after pancreatectomy for cancer: the TNM classification is outdated","volume":"85","author":"Jouffret","year":"2015","journal-title":"ANZ J Surg"},{"issue":"9","key":"10.1016\/j.ajo.2018.07.045_bib10","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1167\/iovs.16-20465","article-title":"Comparison of alternative tumor size classifications for posterior uveal melanomas","volume":"58","author":"Skinner","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2018.07.045_bib11","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2013.03.037","article-title":"Author reply: To PMID 22521086","volume":"120","author":"Harbour","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2018.07.045_bib12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2018.07.045_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2015.11.019","article-title":"Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas","volume":"162","author":"Correa","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2018.07.045_bib14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.eye.6702779","article-title":"Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases","volume":"22","author":"Petrausch","year":"2007","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.ajo.2018.07.045_bib15","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1158\/1078-0432.CCR-06-2401","article-title":"Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma","volume":"13","author":"Worley","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ajo.2018.07.045_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","article-title":"An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma","volume":"12","author":"Onken","year":"2010","journal-title":"J Mol Diagn"},{"issue":"6009","key":"10.1016\/j.ajo.2018.07.045_bib17","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ajo.2018.07.045_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.ajo.2018.07.045_bib19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamaophthalmol.2016.0903","article-title":"Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes","volume":"134","author":"Decatur","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2018.07.045_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.ajo.2018.07.045_bib21","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in uveal melanoma","volume":"22","author":"Field","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"37","key":"10.1016\/j.ajo.2018.07.045_bib22","doi-asserted-by":"crossref","first-page":"59209","DOI":"10.18632\/oncotarget.10962","article-title":"Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas","volume":"7","author":"Field","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ajo.2018.07.045_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/ICU.0000000000000366","article-title":"New concepts in the molecular understanding of uveal melanoma","volume":"28","author":"Reichstein","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2018.07.045_bib24","series-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2017"},{"key":"10.1016\/j.ajo.2018.07.045_bib25","article-title":"The DecisionDx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma","volume":"5","author":"Harbour","year":"2013","journal-title":"PLoS Curr"},{"issue":"1","key":"10.1016\/j.ajo.2018.07.045_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13000-017-0650-3","article-title":"Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics","volume":"12","author":"Plasseraud","year":"2017","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1016\/j.ajo.2018.07.045_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2013.03.011","article-title":"Gene expression profiling versus TNM classification","volume":"120","author":"Harbour","year":"2013","journal-title":"Ophthalmology"},{"issue":"22","key":"10.1016\/j.ajo.2018.07.045_bib28","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","article-title":"Staging of ciliary body and choroidal melanomas based on anatomic extent","volume":"31","author":"Kujala","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ajo.2018.07.045_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrc1739","article-title":"Biomarkers in cancer staging, prognosis and treatment selection","volume":"5","author":"Ludwig","year":"2005","journal-title":"Nat Rev Cancer"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418304380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418304380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:38:34Z","timestamp":1757597914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418304380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":29,"alternative-id":["S0002939418304380"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.07.045","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733793382.793585174","asserted-by":"object"}]},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}